The Asia Pacific Pruritus Therapeutics Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).
The market's primary drivers are leading market firms that make significant R&D investments to produce cutting-edge pruritus cures. Additionally, investments are made to advance existing pruritus treatments. A strong product pipeline and the launch of new medications are top priorities for the major rivals. Moreover, over-the-counter topical medications are in considerable demand due to their low cost, similar effectiveness, and ease of availability. As a result, people are using over-the-counter medications more frequently. These factors create a favorable atmosphere for boosting pruritus product sales as well as for the expansion of the market. In several instances, the cause of the disease is unknown.
Launching novel products to treat the diseases and the high prevalence of dermatological conditions such as atopic dermatitis, urticaria, cutaneous T-cell, psoriasis, and allergic contact dermatitis are expected to fuel market expansion. Pruritus brachialis, pruritus ani, pruritus uremic, nocturnal, and senile pruritus are forms of pruritus that can affect humans and may affect a particular area of the body or the entire body. If the itching is not severe, it can be prevented by keeping the skin clean, moisturized, and free of noticed allergens by avoiding scratching. Pruritus therapeutics are drugs that are used to cure itching.
Over the past few decades, the frequency of atopic dermatitis has increased in Asian nations, specifically worldwide. This increased frequency in Asian nations has been linked to several developments, including rapid urbanization, a shift toward more Westernized lifestyles, and higher living and educational standards. It is crucial to understand the rising disease demand in Asian nations and their variations in terms of epidemiology, diagnostic standards, management, quality of life, and financial burden. The point prevalence of A.D. was 2.42% after normalizing (2.39% in men and 2.46% in women). According to estimates, the market expansion in the APAC region will be supported by the increased prevalence of A.D. in the region.
The China market dominated the Asia Pacific Pruritus Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $786.8 million by 2030. The Japan market is estimated to witness a CAGR of 4.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.7% during (2023 - 2030).
Based on Disease Type, the market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria and Others. Based on Product, the market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Pruritus Therapeutics Market is Projected to reach USD 11.2 Billion by 2030, at a CAGR of 4.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bristol Myers Squibb Company, Novartis AG, Pfizer, Inc., Sanofi S.A., Astellas Pharma, Inc., Cara Therapeutics, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceuticals Industries Ltd., Amgen, Inc., and AbbVie, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Atopic Dermatitis
- Allergic Contact Dermatitis
- Urticaria
- Others
By Product
- Corticosteroids
- Antihistamines
- Local Anesthetics
- Counterirritants
- Immunosuppressant
- Calcineurin Inhibitors
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bristol Myers Squibb Company
- Novartis AG
- Pfizer, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Cara Therapeutics, Inc.
- GlaxoSmithKline PLC (GSK)
- Teva Pharmaceuticals Industries Ltd.
- Amgen, Inc.
- AbbVie, Inc.
TABLE 1 Asia Pacific Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Atopic Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Atopic Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Allergic Contact Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Allergic Contact Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Urticaria Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Urticaria Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Corticosteroids Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Antihistamines Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Local Anesthetics Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Local Anesthetics Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Counterirritants Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Counterirritants Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Immunosuppressant Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Immunosuppressant Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Calcineurin Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Calcineurin Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 33 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 36 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 37 Asia Pacific Pruritus Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 38 Asia Pacific Pruritus Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 39 China Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 40 China Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 41 China Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 42 China Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 43 China Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 44 China Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 45 China Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 China Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Japan Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 48 Japan Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 49 Japan Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 50 Japan Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 51 Japan Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 52 Japan Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 53 Japan Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Japan Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 India Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 56 India Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 57 India Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 58 India Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 59 India Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 60 India Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 61 India Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 India Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 South Korea Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 64 South Korea Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 65 South Korea Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 66 South Korea Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 67 South Korea Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 68 South Korea Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 69 South Korea Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 South Korea Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Singapore Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 72 Singapore Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 73 Singapore Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 74 Singapore Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 75 Singapore Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 76 Singapore Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 77 Singapore Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Singapore Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 79 Malaysia Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 80 Malaysia Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 81 Malaysia Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 82 Malaysia Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 83 Malaysia Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 84 Malaysia Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 85 Malaysia Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Malaysia Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 87 Rest of Asia Pacific Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 89 Rest of Asia Pacific Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 90 Rest of Asia Pacific Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 91 Rest of Asia Pacific Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 92 Rest of Asia Pacific Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 93 Rest of Asia Pacific Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Rest of Asia Pacific Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 95 Key Information – Bristol Myers Squibb Company
TABLE 96 Key Information – Novartis AG
TABLE 97 Key Information – Pfizer, Inc.
TABLE 98 Key Information – Sanofi S.A.
TABLE 99 key information – Astellas Pharma, Inc.
TABLE 100 Key Information – Cara Therapeutics, Inc.
TABLE 101 Key Information – GlaxoSmithKline PLC
TABLE 102 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 103 Key Information – Amgen, Inc.
TABLE 104 Key information – AbbVie, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Pruritus Therapeutics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pruritus Therapeutics Market
FIG 4 Porter’s Five Force Analysis: Pruritus Therapeutics Market
FIG 5 Asia Pacific Pruritus Therapeutics Market share by Disease Type, 2022
FIG 6 Asia Pacific Pruritus Therapeutics Market share by Disease Type, 2030
FIG 7 Asia Pacific Pruritus Therapeutics Market by Disease Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Pruritus Therapeutics Market share by Product, 2022
FIG 9 Asia Pacific Pruritus Therapeutics Market share by Product, 2030
FIG 10 Asia Pacific Pruritus Therapeutics Market by Product, 2019 - 2030, USD Million
FIG 11 Asia Pacific Pruritus Therapeutics Market share by Distribution Channel, 2022
FIG 12 Asia Pacific Pruritus Therapeutics Market share by Distribution Channel, 2030
FIG 13 Asia Pacific Pruritus Therapeutics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Asia Pacific Pruritus Therapeutics Market share by Country, 2022
FIG 15 Asia Pacific Pruritus Therapeutics Market share by Country, 2030
FIG 16 Asia Pacific Pruritus Therapeutics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Bristol Myers Squibb Company
FIG 18 SWOT Analysis: Novartis AG
FIG 19 SWOT Analysis: Pfizer, Inc.
FIG 20 Swot Analysis: Sanofi S.A.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 SWOT Analysis: CARA THERAPEUTICS, INC.
FIG 23 SWOT Analysis: GlaxoSmithKline PLC
FIG 24 Swot Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 Swot Analysis: Amgen, Inc.
FIG 26 Swot Analysis: AbbVie, Inc.